KalVista Pharmaceuticals Inc (KALV)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

55 CAMBRIDGE PARKWAY CAMBRIDGE, MA 02142

Carbylan Therapeutics Inc operates as a clinical-stage specialty pharmaceutical company. The Company focuses on the development and commercialization of medicine for pain treatment associated with osteoarthritis, joint pain relief, and OA pain. Carbylan Therapeutics serves clients globally.

Data based on most recent fiscal year report
Market Cap237.587 Million Shares Outstanding26.34 Million Avg Volume113.452 Thousand
1-Yr BETA vs S&P TR0.989 Current Ratio12.87 Quick Ratio12.87
View SEC Filings from KALV instead.
Q2 2019 All Institutions Hedge Funds 1
To trade KALV now:
Filers who had this stock in their top 10: 4 2 (0.21%)
13F Filers holding this stock: 75 18 (1.86%)
Aggregate 13F shares on 06/30/2019: 14.779 Million 7.233 Million
Aggregate 13F shares on 03/31/2019: 13.906 Million 8.237 Million
Percent change: 6.28% -12.19%
Funds creating new positions: 22 4
Funds Adding to an existing position: 20 7
Funds closing out their position: 17 7
Funds reducing their position: 18 4
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding KALV (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

10 Thousand total shares from 2 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P.

VHCP CO-INVESTMENT HOLDINGS III, LLC

VHCP MANAGEMENT III, LLC

VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P.

VHCP CO-INVESTMENT HOLDINGS II, LLC

VHCP MANAGEMENT II, LLC

KOH BONG Y

SHAH NIMISH P

  • 10% Owner
3,616,873 2019-10-03 0

CHA ALBERT

  • Director
0 2019-10-02 3

UNKART EDWARD W

  • Director
0 2019-10-02 1

ORONSKY ARNOLD L

  • Director
0 2019-10-02 1

SOLAND DANIEL B

  • Director
10,000 2019-09-26 3

RA CAPITAL MANAGEMENT, LLC

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

  • Director
  • 10% Owner
4,681,858 2019-09-17 0

SHAH RAJEEV M.

  • Director
  • 10% Owner
4,681,858 2019-09-17 0

BASTA STEVEN L SEE REMARKS

  • Officer
  • Director
0 2019-07-29 0

NOVO HOLDINGS A/S

  • 10% Owner
2,927,560 2019-07-23 0

YEA CHRISTOPHER CHIEF DEVELOPMENT OFFICER

  • Officer
82,969 2019-07-22 5

FEENER EDWARD P. CHIEF SCIENTIFIC OFFICER

  • Officer
96,734 2019-07-22 4

CROCKETT THOMAS ANDREW CEO

  • Officer
  • Director
248,510 2019-07-15 5

KATKIN KEITH

  • Director
0 2019-07-11 0

EDWARDS MARTIN

  • Director
0 2019-06-26 2

ZADNO REZA PRESIDENT AND CEO

  • Officer
  • Director
0 2019-06-14 0

ALDRICH RICHARD

  • Director
0 2019-06-13 0

LEWIS HAYLEY SEE REMARKS

  • Officer
0 2019-06-11 0

SMITH MICHAEL DAVID SR. VP, DEVELOPMENT

  • Officer
0 2019-05-20 1

PALLEIKO BENJAMIN L CBO, CFO AND SECRETARY

  • Officer
0 2019-05-15 2

MAETZEL ANDREAS SENIOR VICE PRESIDENT MEDICAL

  • Officer
0 2019-05-15 2

SVLSF IV, LLC

SV LIFE SCIENCES FUND IV (GP), L.P.

SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.

SV LIFE SCIENCES FUND IV, L.P.

  • 10% Owner
47,471 2019-04-08 8

PEREIRA BRIAN JG

  • Director
0 2019-02-01 2

RA CAPITAL MANAGEMENT, LLC

KOLCHINSKY PETER

  • Director
  • 10% Owner
7,775,207 2019-01-24 0

RESNICK JOSHUA

  • Director
0 2018-06-20 0

CLAPPER DAVID M

16,252 2018-04-26 0

MARONEY MARCEE VP, CLINICAL AFFAIRS

  • Officer
No longer subject to file 2016-11-21 0

RENZI DAVID PRESIDENT & CEO

  • Officer
  • Director
No longer subject to file 2016-11-21 0

VIVO VENTURES VI, LLC

VIVO VENTURES FUND VI, L.P.

VIVO VENTURES VI AFFIILATES FUND, L.P.

  • 10% Owner
1,787,092 2016-08-18 0

SAUL DAVID JOSEPH

  • Director
0 2016-02-01 0

GRAVETT DAVID M. VP, RESEARCH & DEVELOPMENT

  • Officer
0 2016-01-04 0

RAMIYA PREMCHANDRAN VICE PRESIDENT OF SUPPLY CHAIN

  • Officer
0 2016-01-04 0

MCKUNE JOHN SEE REMARKS

  • Officer
0 2016-01-04 0

NOHRA GUY P

  • Director
No longer subject to file 2015-12-17 0

ACMP IV LLC

ACP IV, L.P.

JANNEY DANIEL

  • 10% Owner
4,343,550 2015-04-14 0

INTERWEST MANAGEMENT PARTNERS IX, LLC

INTERWEST PARTNERS IX, LP

GIANOS PHILIP T

ORONSKY ARNOLD L

KLIMAN GILBERT H

HOLMES W STEPHEN

KJELLSON NINA S

PEPPER DOUGLAS A

CLEVELAND BRUCE A

NASR KHALED

  • 10% Owner
4,619,196 2015-04-14 0

WHITE THOMAS MICHAEL SEE REMARKS

  • Officer
0 2015-04-08 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

UNKART EDWARD W - Director

2019-10-02 A 7,000 $11.21 a 7,000 0.00 direct

CHA ALBERT - Director

2019-10-02 A 7,000 a 7,000 0.00 direct

ORONSKY ARNOLD L - Director

2019-10-02 A 7,000 a 7,000 0.00 direct

SOLAND DANIEL B - Director

2019-09-27 P 7,962 $11.87 a 10,000 10,000.00 direct

SOLAND DANIEL B - Director

2019-09-26 P 2,038 $11.90 a 2,038 10,000.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments